These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
423 related articles for article (PubMed ID: 16757065)
1. Epidemiologic shift in the prevalence of Hepatitis A virus in Saudi Arabia: a case for routine Hepatitis A vaccination. Almuneef MA; Memish ZA; Balkhy HH; Qahtani M; Alotaibi B; Hajeer A; Qasim L; Al Knawy B Vaccine; 2006 Jul; 24(27-28):5599-603. PubMed ID: 16757065 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia. Jaber SM Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474 [TBL] [Abstract][Full Text] [Related]
3. Seroepidemiology of hepatitis A among Greek children indicates that the virus is still prevalent: Implications for universal vaccination. Kyrka A; Tragiannidis A; Cassimos D; Pantelaki K; Tzoufi M; Mavrokosta M; Pedeli X; Athanassiadou F; Hatzimichael A; Konstantopoulos A; Kafetzis D; Papaevangelou V J Med Virol; 2009 Apr; 81(4):582-7. PubMed ID: 19235841 [TBL] [Abstract][Full Text] [Related]
4. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy. Ahmed M; Munshi SU; Nessa A; Ullah MS; Tabassum S; Islam MN Indian J Med Microbiol; 2009; 27(1):48-50. PubMed ID: 19172060 [TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of hepatitis A virus markers in Eastern Saudi Arabia. Fathalla SE; Al-Jama AA; Al-Sheikh IH; Islam SI Saudi Med J; 2000 Oct; 21(10):945-9. PubMed ID: 11369959 [TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of hepatitis A virus antibodies among a sample of Egyptian children. Al-Aziz AM; Awad MA East Mediterr Health J; 2008; 14(5):1028-35. PubMed ID: 19161074 [TBL] [Abstract][Full Text] [Related]
7. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations. Ceyhan M; Yildirim I; Kurt N; Uysal G; Dikici B; Ecevit C; Aydogan A; Koc A; Yasa O; Köseoğlu M; Onal K; Hacimustafaoglu M; Celebi S J Viral Hepat; 2008 Oct; 15 Suppl 2():69-72. PubMed ID: 18837839 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis a in Lebanon: a changing epidemiological pattern. Sacy RG; Haddad M; Baasiri G; Khoriati A; Gerbaka BJ; Abu-Elyazeed R Am J Trop Med Hyg; 2005 Aug; 73(2):453-6. PubMed ID: 16103621 [TBL] [Abstract][Full Text] [Related]
9. Seroprevalence rates of Helicobacter pylori and viral hepatitis A among adolescents in three regions of the Kingdom of Saudi Arabia: is there any correlation? Al Faleh FZ; Ali S; Aljebreen AM; Alhammad E; Abdo AA Helicobacter; 2010 Dec; 15(6):532-7. PubMed ID: 21073610 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of hepatitis A antibodies in schoolchildren in Catalonia (Spain) after the introduction of universal hepatitis A immunization. Domínguez A; Bruguera M; Plans P; Costa J; Salleras L J Med Virol; 2004 Jun; 73(2):172-6. PubMed ID: 15122789 [TBL] [Abstract][Full Text] [Related]
11. Vaccination against hepatitis A virus may not be required for schoolchildren in northern India: results of a seroepidemiological survey. Batra Y; Bhatkal B; Ojha B; Kaur K; Saraya A; Panda SK; Acharya SK Bull World Health Organ; 2002; 80(9):728-31. PubMed ID: 12378291 [TBL] [Abstract][Full Text] [Related]
12. The effect of universal toddlers-only hepatitis A virus vaccination program on seropositivity rate in unvaccinated toddlers: evidence for reduced virus circulation in the community. Barkai G; Belmaker I; Givon-Lavi N; Dagan R Pediatr Infect Dis J; 2009 May; 28(5):391-3. PubMed ID: 19295466 [TBL] [Abstract][Full Text] [Related]
13. [Prevalence of anti-HAV antibodies in Warsaw population]. Janaszek-Seydlitz W; Bucholc B; Wiatrzyk A Przegl Epidemiol; 2007; 61(4):675-82. PubMed ID: 18572499 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis A seroprevalence in children and adults in Kiev City, Ukraine. Moisseeva AV; Marichev IL; Biloschitchkay NA; Pavlenko KI; Novik LV; Kovinko LV; Lyabis OI; Houillon G; Rasuli AM J Viral Hepat; 2008 Oct; 15 Suppl 2():43-6. PubMed ID: 18837833 [TBL] [Abstract][Full Text] [Related]
15. Changing epidemiology of hepatitis A infection in Izmir, Turkey. Kurugol Z; Aslan A; Turkoglu E; Koturoglu G Vaccine; 2011 Aug; 29(37):6259-61. PubMed ID: 21763745 [TBL] [Abstract][Full Text] [Related]
16. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children. Abarca K; Ibánez I; Perret C; Vial P; Zinsou JA Int J Infect Dis; 2008 May; 12(3):270-7. PubMed ID: 17988917 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis a in Korea: epidemiological shift and call for vaccine strategy. Lee D; Cho YA; Park Y; Hwang JH; Kim JW; Kim NY; Lee DH; Lee W; Jeong SH Intervirology; 2008; 51(2):70-4. PubMed ID: 18434743 [TBL] [Abstract][Full Text] [Related]
18. Increasing hepatitis A IgG prevalence rate in men who have sex with men attending a sexual health clinic in London: implications for immunization policy. O'Riordan M; Goh L; Lamba H Int J STD AIDS; 2007 Oct; 18(10):707-10. PubMed ID: 17945051 [TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of hepatitis A virus in patients with chronic liver disease from Kerala: impact on vaccination policy. John A; Chatni S; Narayanan VA; Balakrishnan V; Nair P J Indian Med Assoc; 2009 Dec; 107(12):859-61. PubMed ID: 20509469 [TBL] [Abstract][Full Text] [Related]
20. Seroepidemiology of hepatitis A virus infection among schoolchildren in Taiwan. Tsai CF; Lin DB; Chen SC; Chang YH; Chen CY; Lin JB J Med Virol; 2011 Feb; 83(2):196-200. PubMed ID: 21181912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]